CuraTeQ Biologics

CuraTeQ Biologics is a global biopharmaceutical company and a wholly owned subsidiary of Aurobindo Pharma Limited. Headquartered in Hyderabad, India, the company is dedicated to developing a robust portfolio of high-quality, cost-effective biosimilars, primarily focusing on oncology and immunology therapeutic segments. CuraTeQ operates a state-of-the-art, EU GMP-certified facility that handles end-to-end operations from cell line development to commercial-scale manufacturing. The company has rapidly advanced its pipeline, securing multiple regulatory approvals in highly regulated markets including the EU, UK, and Canada. With a mission to become a leading global biosimilars developer by 2030, CuraTeQ leverages its parent company's extensive manufacturing infrastructure and financial backing to challenge established players in the biologics space.